Routine histological examination of the mastectomy scar at the time of breast reconstruction: Important oncological surveillance?

British Journal of Plastic Surgery

Volumn 57, Issue 2, 2004, Pages 143-145

  Soldin, Mark G ^a,b   Grob, M ^a   Dawson, A ^a   Cooper, M A C S ^a  

^a MORRISTON HOSPITAL   (United Kingdom)

^b KINGSTON HOSPITAL   (United Kingdom)

Author keywords

Mastectomy scar; Oncological surveillance; Routine histology

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN SCAR;

EID: 1242330342     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2003.11.005     Document Type: Article

References (5)

1. Clemons M, Danson S, Hamilton T, Goss P. Locoregional recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev 2001;27:67-82.
2. Granick M, Bragdon R, Hanna D. Recurrent breast carcinoma at the time of breast reconstruction. Ann Plast Surg 1987; 18(1):69-70.
3. Royal College of Pathologists, Histopathology of limited or no clinical value; report of a working group. RCPath 2002.
4. Montandon D. Incidental discovery of recurrent breast carcinoma in patients seeking breast reconstruction. BJPS 1979;32:318-20.
5. Zaworski R, DerHagopian R. Locally recurrent carcinoma after breast reconstruction. Ann Plast Surg 1979;3(4):326-9.